tbuckley/cabot-search huggingface dataset:
Reverse Inflamaging: biological age is accelerated in chronic HCV patients and decelerates after HCV cure
Authors: Carlos Oltmanns, Zhaoli Liu, Jasmin Mischke, Jan Tauwaldt, Yonatan Mekonnen, Heiner Wedemeyer, Anke Kraft, Cheng-Jian Xu, Markus Cornberg
Journal: Journal of Hepatology (2022)
The HBV siRNA, ALG-125755, demonstrates a favourable nonclinical profile and significant and durable hepatitis B surface antigen reductions in the AAV-HBV mouse efficacy model
Authors: Megan Fitzgerald, Kusum Gupta, Kha Le, Sucheta Mukherjee, Jin Hong, Khiem Nguyen, Alfred Chen, Vivek Rajwanshi, Caroline Williams, Meenakshi Venkatraman, Matthew McClure, Sushmita Chanda, John Fry, David Smith, Julian Symons, Lawrence Blatt, Leonid Beigelman, Tse-I Lin
Journal: Journal of Hepatology (2022)
Assessing the applicability of non-invasive diagnostic tests (NITs) in non-alcoholic fatty liver disease: an international qualitative study
Authors: Maja Thiele, Sophie Péloquin, Luca Valenti, Patrice Lazure, Mounia Heddad Masson, Alina Allen, Jeffrey Lazarus, Mazen Noureddin, Mary Rinella, Frank Tacke, Suzanne Murray, Emmanuel Tsochatzis
Journal: Journal of Hepatology (2022)
Evaluation of semisynthetic high-fat diets in development of a 4-week mouse NASH model
Authors: Ozren Majstorović, Maja Antolić, Snježana Čužić, Lucija Mušak, Matea Cedilak, Hrvoje Brzica, Martina Bosnar, Ines Glojnarić
Journal: Journal of Hepatology (2022)
Impact of muscle mass on survival of patients with hepatocellular carcinoma after liver transplantation beyond the Milan criteria
Authors: Berend Beumer, Jeroen van Vugt, Gonzalo Sapisochin, Peter Yoon, Marco Bongini, Di Lu, Xiao Xu, Paolo De Simone, Lorenzo Pintore, Nicolas Golse, Małgorzata Nowosad, William Bennet, Emmanuel Tsochatzis, Evaggelia Koutli, Fariba Abbassi, Marco Claasen, Manuela Merli, Joanne Orourke, Martina Gambato, Alberto Benito, Avik Majumdar, Ek Khoon Tan, Maryam Ebadi, Aldo J Montano-Loza, Marina Berenguer, Herold Metselaar, Wojciech Polak, Vincenzo Mazzaferro, Jan Ijzermans
Journal: Journal of Hepatology (2022)
Alcoholic foamy degeneration: a unique variant of ALD that shows a characteristic pattern of gene expression with upregulation of lipid metabolism and mitochondrial genes and downregulation of fibrosis genes
Authors: Jordi Gratacós-Gines, Delia Blaya, Helena Hernandéz Evole, Carla Montironi, Emma Avitabile, Martina Perez, Marta Cervera, Marta Carol, Ana Belén Rubio, Núria Fabrellas, Anna Soria, Octavi Bassegoda, Laura Napoleone, Ann Ma, Adria Juanola, Isabel Graupera, Alba Díaz, Juan Jose Lozano, Pere Ginès, Elisa Pose
Journal: Journal of Hepatology (2022)
Glycomics-based serum marker as reliable tool for assessment of viral response after treatment with direct-acting antiviral drugs in hepatitis C virus infection
Authors: Nicky Somers, Elisabeth Vandekerckhove, Anja Geerts, Helena Degroote, Sander Lefere, Lindsey Devisscher, Leander Meuris, Nico Callewaert, Hans Van Vlierberghe, Xavier Verhelst
Journal: Journal of Hepatology (2022)
Multispectral imaging analysis of liver biopsies from patients with non-alcoholic steatohepatitis reveals enrichment of pathogenic macrophage phenotypes associated with disease progression
Authors: Joseph Gosnell, Omar Saldarriaga, Santhoshi Krishnan, Morgan Oneka, Arvind Rao, Daniel Millian, Timothy Wanninger, Jingjing Jiao, Laura Beretta, Heather Stevenson
Journal: Journal of Hepatology (2022)
STIGMATIZATION IS COMMON IN PATIENTS WITH METABOLIC ASSOCIATED FATTY LIVER DISEASE AND CORRELATES WITH QUALITY OF LIFE
Authors: Marta Carol, Martina Perez, Elsa Solà, Marta Cervera, Sara Martinez, Adria Juanola, Carlota Riba, Ann Ma, Emma Avitabile, Laura Napoleone, Elisa Pose, Isabel Graupera, Maria Honrubia, Marko Korenjak, Ferran Torres, Pere Ginès, Núria Fabrellas
Journal: Journal of Hepatology (2022)
The protective effect of time-caloric restriction in liver fibrosis induced by nitrosamines in rat model
Authors: Christian Molina-Aguilar, Fernanda Arriaga-González, Felipe Castañeda, Kevin Villa-Malagon, Irving Simonin-Wilmer, Obed Ramírez Sánchez, Emilio Calderón Garza, Mayra López Azuara, Osiel Ledesma Juárez, Martín del Castillo Velasco-Herrera, David Adams, Mauricio Díaz-Muñoz, Carla Daniela Robles-Espinoza
Journal: Journal of Hepatology (2022)
PD-1/PD-L1 pathway is related to infection development and early mortality in patients with cirrhosis
Authors: Adria Juanola, Elisa Pose, Delia Blaya, Cristina Solé, Gabriel Mezzano, Natalia Jimenez-Esquivel, Joaquin Andrés Castillo, Jordi Ribera, Irene Portoles, Martina Perez, Ann Ma, Laura Napoleone, Ana Belén Rubio, Marta Cervera, Marta Carol, Octavi Bassegoda, Jordi Gratacós-Gines, Anna Soria, Núria Fabrellas, Manuel Morales-Ruiz, Mar Coll, Isabel Graupera, Gonzalo Crespo, Elsa Solà, Pere Ginès
Journal: Journal of Hepatology (2022)
Classification of HCV-specific CD8+ T cells by the differential expression pattern of Slamf6 and CD69 predicts that the majority of cells are rather preterminally versus terminally exhausted regardless of disease stage
Authors: Maximilian Knapp, Christin Ackermann, Claudia Beisel, Vanessa Ditt, Melanie Wittner, Julian Schulze Zur Wiesch
Journal: Journal of Hepatology (2022)
Coagulation imbalance is associated with hepatic fibrosis and vascular complications in patients with type2 diabetes and NAFLD
Authors: Francesca Alletto, Paolo Francione, Gabriele Maffi, Giordano Sigon, Annalisa Cespiati, Daniela Bignamini, Mariagrazia Clerici, Veena Chantarangkul, Armando Tripodi, Flora Peyvandi, Silvia Fargion, Anna Ludovica Fracanzani, Rosa Lombardi
Journal: Journal of Hepatology (2022)
Humoral and cellular immunity after vaccination against SARS-CoV-2 is reduced in patients with chronic liver disease
Authors: Al-Dury Samer, Johan Waern, Anna Martner, Hevar Hamah Saed, Marko Alavanja, Johan Ringlander, Andreas Törnell, Mohammad Arabpour, Jesper Waldenström, Hanna Grauers Wiktorin, Gisela Ringström, Martin Lagging
Journal: Journal of Hepatology (2022)
Beta-blockers can reduce mortality in patients with acute-on-chronic liver failure-a multi-center study
Authors: Anand Kulkarni, Madhumita Premkumar, Karan Kumar, Juned Khan, Baqar Gora, Sowmya Iyengar, Mithun Sharma, Nageshwar Reddy, Nagaraja Rao Padaki
Journal: Journal of Hepatology (2022)
The rs429358 apolipoprotein E (APOE) polymorphism is associated with increased liver injury in patients with autoimmune hepatitis
Authors: Maciej K. Janik, Wiktor Smyk, Beata Kruk, Benedykt Szczepankiewicz, Barbara Górnicka, Susanne N Weber, Piotr Milkiewicz, Marcin Krawczyk
Journal: Journal of Hepatology (2022)
Randomized, double-blind, placebo-controlled trial of Tenofovir Alafenamide in children and adolescents with chronic hepatitis B
Authors: Kathleen Schwarz, Jorge Bezerra, Byung-Ho Choe, Chuan-Hao Lin, Frida Abramov, Anh-Hoa Nguyen, Yang Liu, Rory Leisegang, John F. Flaherty, Daniela Pacurar, Kyung Mo Kim, Ilsiyar Khaertynova, Shalimar, Jia-Feng Wu, Manish Tandon, Philip Rosenthal, Morozov Viacheslav, Etienne Sokal, Mei-Hwei Chang
Journal: Journal of Hepatology (2022)
Longitudinal follow-up data on adults with classic, severe alpha-1 antitrypsin deficiency (Pi*ZZ genotype)
Authors: Malin Fromme, Samira Amzou, Barbara Burbaum, Philipp Striedl, Mattias Mandorfer, Elmar Aigner, Christian Trautwein, Pavel Strnad
Journal: Journal of Hepatology (2022)
Butyrate protects against diet-induced NASH and liver fibrosis and suppresses specific non-canonical TGFB signaling pathways in human hepatic stellate cells
Authors: Eveline Gart, Wim van Duyvenvoorde, Karin Toet, Martien P.M Caspers, Lars Verschuren, Aswin L. Menke, Roeland Hanemaaijer, Jaap Keijer, Kanita Salic, Robert Kleemann, Martine C. Morrison
Journal: Journal of Hepatology (2022)
Low hemoglobin level predicts early hospital readmission in patients with cirrhosis and acute decompensation
Authors: Enrico Pompili, Maurizio Baldassarre, Giacomo Zaccherini, Manuel Tufoni, Giulia Iannone, Dario Pratelli, Clara De Venuto, Marco Domenicali, Paolo Caraceni
Journal: Journal of Hepatology (2022)
In women with stress UI, device-guided pelvic floor muscle training safely improved symptoms more than self-guided training
Authors: Robert P. Kauffman
Journal: Annals of Internal Medicine (2022)

ACP Journal ClubJuly 2022In women with stress UI, device-guided pelvic floor muscle training safely improved symptoms more than self-guided trainingRobert P. Kauffman, MDRobert P. Kauffman, MDTexas Tech University HSC School of Medicine, Amarillo, Texas, USA (R.P.K.)Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/J22-0044 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Source CitationWeinstein MM, Dunivan G, Guaderrama NM, et al. Digital therapeutic device for urinary incontinence: a randomized controlled trial. Obstet Gynecol. 2022;139:606-15. https://pubmed.ncbi.nlm.nih.gov/35271539Clinical Impact RatingsGIM/FP/GP: References1. Pizzol D, Demurtas J, Celotto S, et al. Urinary incontinence and quality of life: a systematic review and meta-analysis. Aging Clin Exp Res. 2021;33:25-35. [PMID: 32964401] Google Scholar2. Imamura M, Hudson J, Wallace SA, et al. Surgical interventions for women with stress urinary incontinence: systematic review and network meta-analysis of randomized controlled trials. BMJ. 2019;365:I1842. [PMID: 31167796] Google Scholar3. Cho ST, Kim KH. Pelvic floor muscle exercise and training for coping with urinary incontinence. J Exerc Rehabil. 2021;17:379-87. [PMID: 35036386] Google Scholar Author, Article, and Disclosure InformationAffiliations: Texas Tech University HSC School of Medicine, Amarillo, Texas, USA (R.P.K.)Disclosures: The commentator has reported no disclosures of interest. The form can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=J22-0044.This article was published at Annals.org 5 July 2022. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics July 2022Volume 175, Issue 7Page: JC79KeywordsExerciseIncontinenceMusclesPelvisSafetySexual dysfunctionUrinary incontinenceUrineUrodynamics ePublished: 5 July 2022 Issue Published: July 2022 Copyright & PermissionsCopyright © 2022 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...
The co-presence of PNPLA3, MBOAT7 and TM6SF2 loss-of-functions impairs mitochondrial morphology and number in severe NAFLD patients
Authors: Miriam Longo, Erika Paolini, Marica Meroni, Michela Ripolone, Laura Napoli, Roberto Piciotti, Marco Maggioni, Maurizio Moggio, Anna Ludovica Fracanzani, Paola Dongiovanni
Journal: Journal of Hepatology (2022)
Machine learning methods for detailed characterization of TGF-beta-induced signatures in a large iPSC-derived hepatic stellate cell cohort
Authors: Panagiotis Stanitsas, Kara Marie Liu, Lorn Kategaya, Kelly Haston, Alicia Lee, Shahin Mohammadi, Haoyang Zheng, Francesco Paolo Casale, Navpreet Ranu, Ahmed Sandakli, Pooja Prasad, Owen Chen, Anne Baldwin, Albert Kim, Eilon Sharon, Ajamete Kaykas, Daphne Koller, Matthew Albert
Journal: Journal of Hepatology (2022)
Impact of maternal obesity on liver disease in the offspring: a comprehensive transcriptomic analysis and validation of results
Authors: Beat Moeckli, Vaihere Delaune, Julien Prados, Matthieu Tihy, Andrea Peloso, Graziano Oldani, Thomas Delmi, Nicolas Goossens, Laura Rubbia-Brandt, Stéphanie Lacotte, Christian Toso
Journal: Journal of Hepatology (2022)
Durability of immune response to SARS-CoV-2 vaccination in patients with liver cirrhosis (LC) as compared to healthcare workers (HW)
Authors: Alessandra Mangia, Valeria Piazzolla, Maria Squillante, Giovanna Cocomazzi, Vito Ciciriello, Vincenzo Giambra, Nicola Serra
Journal: Journal of Hepatology (2022)
Risk factors for short-term post discharge clinical outcomes in patients hospitalized with decompensated chronic liver disease: interim results from Global CLEARED study
Authors: Jasmohan S. Bajaj, Patrick S. Kamath, Florence Wong, Peter Hayes, Ramazan Idilman, Aldo Torre, Mark Topazian, Jacob George, Mario Reis Álvares-da-Silva, Qing Xie, Shiv Kumar Sarin, Abha Nagral, Sumeet Asrani, Mohammad Amin Fallahzadeh, Somaya Albhaisi, CE Eapen, Ashish Goel, Ajay Kumar Duseja, Anoop Saraya, Jatin Yegurla, Mohd. Rela, Dinesh Jothimani, Marie Jeanne Lohoues, Belimi Hibat Allah, Ricardo Cabello, Ruveena Bhavani, Nik MA Nik Arsyad, Sombat Treeprasertsuk, Salisa Wejnaruemarn, Jose Luis Perez Hernandez, Godolfino Miranda Zazueta, Neil Rajoriya, Rosemary Faulkes, Abdullah Emre Yıldırım, Sezgin Barutcu, Anand Kulkarni, Mithun Sharma, Rajender Reddy, Suditi Rahematpura, Adebayo Danielle, James Kennedy, Feyza Gunduz, Rahmi Aslan, Anil Arora, Ashish Kumar, Dalia Allam, Yashwi Haresh Kumar Patwa, Mauricio Castillo, Hiang Keat Tan, Liou Wei Lun, Hugo E. Vargas, David Bayne, Paul J. Thuluvath, Somya Sheshadri, Ajay Haveri, Andrew Keaveny, Jawaid Shaw, Edith Okeke, Nyam P David, Aloysious Aravinthan, Suresh Vasan Venkatachalapathy, Amey Sonavane, Hailemichael Desalegn, Henok Fisseha, Dominik Bettinger, Michael Schultheiss, Scott Biggins, Natalia Filipek, Damien Leith, Ewan Forrest, Maria Sarai González-Huezo, René Malé Velazquez, Lilian Torres Made, Diana Yung, Zeki Karasu, Zhujun Cao, Helena Katzman, Liane Rabinowich, Carlos Benitez, Andres Duarte Rojo, Sebastián Marciano, Akash Gandotra, Brian Bush, Leroy Thacker, Ashok Choudhury
Journal: Journal of Hepatology (2022)
Search for biomarkers and prognostic indicators of liver degeneration in glycogen storage disease type Ia
Authors: Roberta Resaz, Davide Cangelosi, Daniela Segalerba, Martina Morini, Maria Carla Bosco, Sabrina Paci, Annalisa Sechi, Daniela Melis, Maja Di Rocco, David Weinstein, Alessandra Eva
Journal: Journal of Hepatology (2022)
Patient engagement in hepatitis B clinical trials: ‘HBV cure’ is a motivation for participation in all ethnically diverse patients
Authors: Almuthana Mohamed, Akudo Nwaogu, Dusan Jovovic, James Lok, Maria Guerra Veloz, Khin Aye Wint Han, Jeya Anice Sundararaj, Andrew Ayers, Ivana Carey, Kosh Agarwal
Journal: Journal of Hepatology (2022)
Factor VIII/protein C ratio does not reflect coagulation but is linked to pathophysiological mechanisms driving disease progression in patients with advanced chronic liver disease
Authors: Lorenz Balcar, Bernhard Scheiner, Rafael Paternostro, Benedikt Simbrunner, Lukas Hartl, Mathias Jachs, David JM Bauer, Albert Stättermayer, Georg Semmler, Matthias Pinter, Peter Quehenberger, Michael Trauner, Thomas Reiberger, Ton Lisman, Mattias Mandorfer
Journal: Journal of Hepatology (2022)
Increased HBsAg reduction and relapse outcomes in HBeAg negative patients with chronic hepatitis B after nucleos (t)ide analogue withdrawal: 4.5 year follow-up of the Toronto STOP Study
Authors: Arif Sarowar, Seng Liem, Scott K Fung, David Wong, Jordan Feld, Colina Yim, Seham Noureldin, Jenny Chen, Bettina Hansen, Harry Janssen
Journal: Journal of Hepatology (2022)
De-novo occurrence of portal vein thrombosis in patients with HCV-related cirrhosis after sustained virological response: medium to long term observations from the ongoing PITER cohort
Authors: Loreta Kondili, Maria Giovanna Quaranta, Luigina Ferrigno, Carmine Coppola, Monica Monti, Roberto Filomia, Giuseppina Brancaccio, Maurizia Brunetto, Elisa Biliotti, Donatella Ieluzzi, Andrea Iannone, Salvatore Madonia, Xhimi Tata, Luisa Cavalletto, Valentina Cossiga, Simona Amodeo, Vincenza Calvaruso, Elena Rosselli Del Turco, Maria Grazia Rumi, Maurizio Pompili, Alessia Ciancio, Lucia Brescini, Francesco Paolo Russo
Journal: Journal of Hepatology (2022)
Plasma sgp130 is an independent predictor of non-alcoholic fatty liver disease severity
Authors: Aysim Gunes, Laurent Bilodeau, Catherine Huet, Assia Belblidia, Cindy Baldwin, Jeanne-Marie Giard, Laurent Biertho, Annie Lafortune, Christian Couture, Bich N. Guyen, Eithan Galun, Chantal Bemeur, Marc Bilodeau, Mathieu Laplante, An Tang, May Faraj, Jennifer Estall
Journal: Journal of Hepatology (2022)
Hepatitis C virus reinfection following direct acting antiviral treatment in the prison setting: the SToP-C study
Authors: Joanne Carson, Gregory Dore, Andrew Lloyd, Jason Grebely, Marianne Byrne, Evan B Cunningham, Janaki Amin, Peter Vickerman, Natasha Martin, Carla Treloar, Gail Matthews, Behzad Hajarizadeh
Journal: Journal of Hepatology (2022)
Tenofovir alafenamide for pregnant chinese women with active chronic hepatitis B: a multicenter, prospective, real-world study
Authors: Qing-Lei Zeng, Hongxu Zhang, Ji-Yuan Zhang, Shuo Huang, Wei-Zhe Li, Guangming Li, Ying-Hua Feng, Guofan Zhang, Jiang-Hai Xu, Wan-Bao Lin, Guang-Hua Xu, Guoqiang Zhang, Yan-Li Zeng, Zu-Jiang Yu, Fu-Sheng Wang
Journal: Journal of Hepatology (2022)
TIA1 in fatty liver disease and hepatocellular carcinoma
Authors: Dobrochna Dolicka, Szabolcs Zahoran, Marta Sousa, Monika Gjorgjieva, Christine Sempoux, Margot Fournier, Christine Maeder, Martine Collart, Michelangelo Foti, Cyril Sobolewski
Journal: Journal of Hepatology (2022)
Liver stiffness and autoimmune profile in a cohort of patients with systemic sclerosis
Authors: Davide Di Benedetto, Maria Lorena, Francesca Baorda, Giulia Francesca Manfredi, Antonio Acquaviva, Carla De Benedittis, Cristina Rigamonti, Mattia Bellan, Mario Pirisi
Journal: Journal of Hepatology (2022)
Characterization of IG-MYC-breakpoints and their application for quantitative minimal disease monitoring in high-risk pediatric Burkitt-lymphoma and -leukemia
Authors: Paula Möker, Udo zur Stadt, Martin Zimmermann, Malik Alawi, Stephanie Mueller, Jasmin Finger, Fabian Knörr, Amambay Riquelme, Ilske Oschlies, Wolfram Klapper, Jutta Bradtke, Birgit Burkhardt, Wilhelm Woessmann, Christine Damm-Welk
Journal: Leukemia (2022)

The cure rate of children with Burkitt lymphoma (BL) and -leukemia (B-AL) reaches 90% with NHL-BFM-type chemotherapy.Only children with clinical high-risk disease (stage III or IV, LDH > 500U/l and/or CNS-involvement, risk groups R3 and R4; supplementary table 1) have a relapse rate exceeding 15% and their survival at relapse is 20% [1][2][3][4].Therefore, early identification of children with highest risk of relapse among clinical high-risk patients is essential for further therapy optimization.The goal of our study was to analyze the prognostic value of IG-MYCbreakpoints from the hallmark translocations t(8;14) (IGH-MYC), t (2;8) (IgK-MYC) and t(8;22) (IGL-MYC) and apply them to evaluate quantitative minimal disseminated disease (MDD, for BL) or minimal residual disease (MRD, for B-AL) as risk factors among children with high-risk disease.We determined IG-MYC-breakpoints in samples from children with BL/B-AL, risk groups R3 and R4, treated with identical chemotherapy in NHL-BFM studies/-registry between 2000 and 02/2017 (supplementary patient data) for whom frozen or FFPE initial tumor material, and frozen bone marrow cells from either initial punctures (93 BL, for MDD) or before the second course of chemotherapy (50 B-AL, for MRD) were available.The patient characteristics of the 143 BL/B-AL patients are shown in supplementary table 2. EFS and survival of the group were 80 ± 3% and 83 ± 3%, respectively.The breakpoint distributions of the translocations t(8;14), t(2;8) and t(8;22) in BL/B-AL reported so far often were analyzed by methods excluding chromosome 8-breakpoints far 3´of MYC and/ or in limited cohorts of patients due to the necessity of available frozen tumor material [5][6][7][8].Using a long-distance PCR for IGH-MYC and Sanger sequencing in cases with frozen tumor samples or a genomic capture high-throughput sequencing (gc-hts) assay for IGH-MYC-negative cases and those with FFPE tumor DNA
Scheduled endoscopic program for patients with primary sclerosing cholangitis improves transplant-free survival and enables early risk stratification
Authors: Burcin Özdirik, Wilfried Veltzke-Schlieker, Jule-Marie Nicklas, Hilmar Berger, Daniel Schmidt, Silke Leonhardt, Andreas Adler, Tobias Müller, Alexander Wree, Frank Tacke, Michael Sigal
Journal: Journal of Hepatology (2022)
Novel and accurate measurement of differential protease activity in diagnosed HCC patients compared to non-HCC cirrhotic patients
Authors: Amit Singal, Tram Tran, Ben Holmes, Chris Gulka, Anatoly Myaskovsky, Andrea Shepard, Mackenzie Rowe, Sophie Cazanave, Faycal Touti, Jina Lee, Alejandro Balbin, Wendy Winckler
Journal: Journal of Hepatology (2022)
ATA haplotype of the interleukin-10 gene and low phase angle are associated with liver cirrhosis in chronic hepatitis C
Authors: Nataly Lopes Viana, Diego Alves Vieira, Thais Pontelo de Vries, Marta Paula Pereira Coelho, Pedro Alves de Castro, Tatiana Bering Bering, Maria Isabel Toulson Davidson Correia, Gifone Aguiar Rocha, Luciana Diniz Silva
Journal: Journal of Hepatology (2022)
Lanifibranor therapy reduces the FibroScan-aspartate aminotransferase (FAST) score associated with histological ‘NASH resolution and improvement of fibrosis’ and biomarker response
Authors: Michael Cooreman, Manal Abdelmalek, Martine Baudin, Philippe Huot-Marchand, Lucile Dzen, Céline Fournier, Jean-Louis Junien, Pierre Broqua, Sven Francque
Journal: Journal of Hepatology (2022)
Isolated IgG elevation is not associated with worse outcome in patients with autoimmune hepatitis
Authors: Alvaro Diaz Gonzalez, Lorena Carballo-Folgoso, Carmen Álvarez-Navascués, Judith Gómez-Camarero, Diana Horta, Beatriz Mateos Muñoz, María Del Barrio, Marina Cobreros, Sergio Rodriguez-Tajes, Olivas Ignasi, Indhira Perez Medrano, Inmaculada Castello, Alberto Gómez, Manuel Rodríguez-Perálvarez, Javier Crespo, Magdalena Salcedo, Ana Barreira, Mar Riveiro Barciela, Maria Carlota Londoño
Journal: Journal of Hepatology (2022)
Infrequent hepatitis C genotypes/subtypes in patients treated with DAA-based regimens: successes and failures
Authors: Donald Murphy, Isaac Ruiz, Jean-Pierre Villeneuve, Catherine Vincent, Julian Hercun, Daphna Fenyves, Denis Marleau, Helene Castel, Julien Bissonnette, Genevieve Huard, Claire Fournier, Jeanne-Marie Giard, Daniel Corsilli, Ziad Hassoun, Philippe Willems, Iris Soto, Marc Bilodeau, Bernard Willems
Journal: Journal of Hepatology (2022)
Presence of two or more metabolic risks regardless of fatty liver is a risk factor for significant hepatic fibrosis
Authors: Huiyul Park, Dae Won Jun, Eileen Yoon, Sang Bong Ahn, Hyo Young Lee, Hyunwoo Oh, Bo-Kyeong Kang, Mi Mi Kim, Chul-min Lee, Joo Hyun Sohn
Journal: Journal of Hepatology (2022)
Amino acid glycine suppresses steatohepatitis and tumorigenesis in hepatocyte-specific phosphatase and tensin homolog knockout mice
Authors: Kazuyoshi Kon, Kumiko Arai, Akira Uchiyama, Hiroo Fukada, Toshifumi Sato, Maki Morinaga, Kyoko Fukuhara, Reiko Yaginuma, Shunhei Yamashina, Kenichi Ikejima
Journal: Journal of Hepatology (2022)
Integrative clustering of multiple genomic data using organoid model with application to subtype analysis in intrahepatic cholangiocarcinoma
Authors: Hee Seung Lee, Dai Hoon Han, Kyung Joo Cho, Soo Been Park, Chanyang Kim, Galam Leem, Soon Sung Kwon, Chul Hoon Kim, Jung Hyun Jo, Hye Won Lee, Si Young Song, Jun Yong Park
Journal: Journal of Hepatology (2022)
MAP17 promotes metastasis in hepatocellular carcinoma by modulating the epithelial-mesenchymal-amoeboid transition
Authors: Claudia Gil-Pitarch, Esther Bertran, Iker Uriarte, Natalia Hermán-Sánchez, José Manuel García-Heredia, Naroa Goikoetxea, Marina Serrano-Macia, Rubén Rodríguez Agudo, Sofia Lachiondo-Ortega, Maria Mercado-Gómez, Miriam Rábano, Teresa Cardoso Delgado, Jorge Simón Espinosa, Luis Alfonso Martinez-Cruz, Cesar Augusto Martín, Maria Vivanco, Matías A. Avila, Manuel Gahete Ortiz, Isabel Fabregat, Amancio Carnero, María Luz Martínez-Chantar
Journal: Journal of Hepatology (2022)
Trends and causes of etiology in adult liver transplant patients: multicenter study
Authors: Mesut Akarsu, Murat Harputluoglu, Sezai Yilmaz, Genco Gencdal, Murat Akyildiz, Kamil Yalcin Polat, Dinc Dincer, Haydar Adanir, Ilker Turan, Fulya Günsar, Zeki Karasu, Hale Gokcan, Sedat Karademir, Gökhan Kabaçam, Meral Akdogan Kayhan, Murat Kiyici, Murat Taner Gulsen, Hatice Yasemin Balaban, Ahmet Bulent Dogrul, Suleyman Dolu, Ali Senkaya, Zeynep Melekoğlu Ellik, Fatih Eren, Ramazan Idilman
Journal: Journal of Hepatology (2022)